IOV-5001

N/A

Report date: 2024/05/28 17:59:51

Base Information

Drug NameIOV-5001

Drug Alias NameCytokine-tethered TIL therapy (Iovance Biotherapeutics)Tethered IL-12 TIL cell therapy (Iovance Biotherapeutics)IOV-5001

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Tumor Infiltrating Lymphocytes

Mechanisms of ActionInterleukin-12 stimulantsLymphocyte replacementsImmunologic cytotoxicity

TargetsInterleukin-12

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesIovance Biotherapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesIovance Biotherapeutics Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A